Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 1,395,371 | reported | 10 May 2022 | tx 53+6,873,441−1,590,225 |
| Bausch & Lomb Corp | 472,222 | reported | 05 May 2022 | tx 2+2,340,353 |
| Emergent BioSolutions Inc. | 305,445 | reported | 05 Mar 2026 | tx 8+2,127,194−37,055 |
| Milestone Pharmaceuticals Inc. | 100,000 | reported | 11 Jul 2025 | tx 5+420,000 |
| Candel Therapeutics, Inc. | 64,239 | reported | 25 Jun 2025 | tx 7+173,471 |
| WATSON PHARMACEUTICALS INC | 40,000 | reported | 22 Nov 2003 | tx 1+40,000 |
| PERRIGO Co plc | 13,077 | reported | 26 Feb 2016 | tx 45+556,867−106,961 |
| PERRIGO CO | 0 | reported | 18 Dec 2013 | tx 227+1,363,864−1,442,214 |
| Prometheus Biosciences, Inc. | 0 | reported | 16 Jun 2023 | tx 13+51,994−116,986 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | TAX_WITHHOLDING | Emergent BioSolutions Inc. | 37,055 | 8.44 USD | |
| 03 Mar 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 252,194 | 0.00 USD | deriv |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 100,000 | — | |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 100,000 | — | deriv |
| 11 Jul 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 100,000 | — | deriv |
| 25 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 64,239 | 4.67 USD | |
| 17 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 13 May 2025 | PURCHASE | Emergent BioSolutions Inc. | 60,000 | 5.83 USD | first after silence |
| 12 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 250,000 | 0.00 USD | deriv |
| 12 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 250,000 | 0.00 USD | deriv |
| 06 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 282,500 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 282,500 | 0.00 USD | deriv |
| 03 Sept 2024 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 80,000 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 13 Mar 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 750,000 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 7,278 | — | |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 10,000 | — | |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 22,551 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 2,165 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 22,652 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 15,000 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 27,340 | — | deriv |
| 02 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 10,000 | 0.00 USD |
4 purchases reported after at least 12 months of silence — most recent on 13 May 2025.